XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED BALANCE SHEET - UNAUDITED - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets    
Cash and cash equivalents ($852 and $630 related to VIEs) $ 2,436 $ 2,209
Marketable securities ($98 and $90 related to VIEs) 155 127
Accounts receivable, net ($192 and $173 related to VIEs) 1,007 1,171
Contract assets ($219 and $223 related to VIEs) 1,012 1,066
Other current assets ($34 and $28 related to VIEs) 381 608
Total current assets 4,991 5,181
Noncurrent assets    
Property, plant and equipment, net ($43 and $46 related to VIEs) 460 456
Investments 612 517
Deferred taxes 50 51
Deferred compensation trusts 225 330
Goodwill 244 249
Other assets ($41 and $45 related to VIEs) 288 305
Total noncurrent assets 1,879 1,908
Total assets 6,870 7,089
Current liabilities    
Accounts payable ($277 and $261 related to VIEs) 1,071 1,220
Short-term debt and current portion of long-term debt 167 18
Contract liabilities ($361 and $351 related to VIEs) 769 945
Accrued salaries, wages and benefits ($20 and $27 related to VIEs) 567 629
Other accrued liabilities ($31 and $33 related to VIEs) 637 802
Total current liabilities 3,211 3,614
Long-term debt 980 1,174
Deferred taxes 63 67
Other noncurrent liabilities ($55 and $13 related to VIEs) 586 667
Contingencies and commitments
Temporary APIC 107 0
Shareholders’ equity    
Preferred stock — authorized 20,000,000 shares ($0.01 par value); issued and outstanding — 600,000 shares in 2022 and 2021 0 0
Common stock — authorized 375,000,000 shares ($0.01 par value); issued and outstanding — 142,082,682 and 141,434,771 shares in 2022 and 2021, respectively 1 1
APIC 1,129 967
AOCI (378) (366)
Retained earnings 898 791
Total shareholders’ equity 1,650 1,393
NCI 273 174
Total equity 1,923 1,567
Total liabilities and equity $ 6,870 $ 7,089